ATF4 and breast carcinoma: MDA-MB-231 breast cancer cells were treated with CB-839 for 8 h; cross-linked chromatin was then digested to a length of ~150–900 bp, and an antibody against ATF4 was used to precipitate ATF4/DNA complexes.